Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antiallergic agents from Hisamitsu

March 25, 1997

RPR files for U.S. approval of CFC-free asthma inhalater

March 21, 1997

Hisamitsu claims novel antiallergic agents

March 21, 1997

Pharm-Eco to manufacture Inflazyme's Apanol

March 19, 1997

Pivotal trial data reported for levalbuterol

March 19, 1997

Peptides for Japanese cedar allergies reported by Sankyo and Hayashibara

March 18, 1997

Astra gains European approval of asthma treatment

March 17, 1997

Bronchodilating effect of furosemide not secondary to prostaglandin release

March 14, 1997

Montelukast associated wth bronchodilating effects in asthmatics

March 14, 1997

Fluticasone associated with more adrenal suppression than budesonide

March 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...